Flu like symptoms; Bruise was tender and hurts to the touch; Bruise was tender and hurts to the touch; Injection site bruised; Injection site hot; Injection site lump; Injection site sore; There was a bruise at injection site, a red blotch that was growing bigger each day; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), CONTUSION (Bruise was tender and hurts to the touch), TENDERNESS (Bruise was tender and hurts to the touch), VACCINATION SITE BRUISING (Injection site bruised) and VACCINATION SITE WARMTH (Injection site hot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904, 028L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Allergy to antibiotic (Bacitracin), Allergy to chemicals (Artificial lubricant), Latex allergy, Allergy to animal dander (Pet dander), Hypercholesterolemia (High cholesterol) since 2001, Hyperlipidemia and Dry eye. Concomitant products included LINUM USITATISSIMUM SEED OIL (FLAX SEED OIL) for Dry eye, NUTRAFOL for Hair disorder, ROSUVASTATIN CALCIUM (CRESTOR) for Hyperlipidemia, MELOXICAM and UBIDECARENONE (COQ-10) for an unknown indication.   On 23-Dec-2020 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021 at 2:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021 at 3:15 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 02-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), CONTUSION (Bruise was tender and hurts to the touch), TENDERNESS (Bruise was tender and hurts to the touch), VACCINATION SITE BRUISING (Injection site bruised), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE MASS (Injection site lump), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE ERYTHEMA (There was a bruise at injection site, a red blotch that was growing bigger each day). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) for Adverse event, at a dose of 500 mg three times a day. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), CONTUSION (Bruise was tender and hurts to the touch), TENDERNESS (Bruise was tender and hurts to the touch), VACCINATION SITE BRUISING (Injection site bruised), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE MASS (Injection site lump), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE ERYTHEMA (There was a bruise at injection site, a red blotch that was growing bigger each day) had not resolved.            Vaccination route was reported as injection. Nutrafol was indicated for hair supplement.  Indication for COQ-10 was reported as taking statin.  On 03-Nov-2021 Red blotch was larger, sore to touch and very hot. On 04-N0v-2021 Blotch was became larger with some other issues. On 05-Nov-2021  blotch was quit larger, feels hot and sore to touch.  Patient stated that his arm was improving and still taking the course that prescribed by the doctor.   Most recent FOLLOW-UP information incorporated above includes: On 10-Nov-2021: Follow up received and added medical history, Patient demographics , Race and ethnicity. Updated booster dose ,anatomical location. Concomitant medication with indication updated. New Events Vaccination site warmth, vaccination site mass, vaccination site pain, vaccination site erythema added.